WallStreetZenWallStreetZen

NASDAQ: LTGO
Latigo Biotherapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Latigo Biotherapeutics earnings were N/A for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest LTGO earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$20.9M, down 18.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LTGO reported annual earnings of -$109.2M, with 78.4% growth.

LTGO earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

LTGO Return on Equity

Insufficient data to display

LTGO Return on Assets

Insufficient data to display

Be the first to know when LTGO announces earnings.

LTGO Return on Capital Employed

Current Company
0%
Current Industry
-4.4%

LTGO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LTGON/AN/AN/AN/A
IVA-$80.95M-$281.82MN/A-$0.60
SNDX-$161.59M-$209.48MN/A-$2.36
PHAR$51.54M$26.93M-0.45%$0.39
MGTX$102.47M$78.28MN/A$0.85
View Top Biotech Stocks

Latigo Biotherapeutics Earnings Reports & History FAQ

What were Latigo Biotherapeutics's earnings last quarter?

On LTGO's earnings call on Nov 5, 2026, Latigo Biotherapeutics (NASDAQ: LTGO) reported Q3 2026 earnings per share (EPS) of -$0.55, up 98.14% year over year. Total LTGO earnings for the quarter were -$20.95 million. In the same quarter last year, Latigo Biotherapeutics's earnings per share (EPS) was -$29.50.

If you're new to stock investing, here's how to buy Latigo Biotherapeutics stock.

Is Latigo Biotherapeutics profitable or losing money?

As of the last Latigo Biotherapeutics earnings report, Latigo Biotherapeutics is currently losing money. Latigo Biotherapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2026 was N/A, a N/A decrease year over year.

What was LTGO's earnings growth in the past year?

As of Latigo Biotherapeutics's earnings date in Nov 5, 2026, Latigo Biotherapeutics's earnings has grown year over year. LTGO earnings in the past year totalled N/A.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.